No More New Molecule For Cardiovascular Ailments as Pharmaceutical Firms Shift Focus
Pharmaceutical Firms Shy away from Cardio Molecule Research Lipitor innovator Pfizer too has shifted focus from Cardiovascular Ailments to other Diseases.
Realpharmacyrx.com: A recent issue of British medical journal The Lancet found that heart diseases kill 3 million people in India annually, accounting for a third of the total deaths in the country. The World Health [...]
